Role of protein-tyrosine phosphatases in regulation of osteoclastic activity

Cellular and Molecular Life Sciences

Volumn 66, Issue 11-12, 2009, Pages 1946-1961

  Sheng, M H C ^a,b   Lau, K H W ^a,b  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone resorption; c Src; Cytosolic PTP ; Osteoclast; Protein tyrosine dephosphorylation; Protein tyrosine phosphatases; PTP oc; PTP PEST; SHP 1

Indexed keywords

ISOPROTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE C SRC; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN-TYROSINE KINASE C-SRC; TYROSINE;

ANIMAL; ARTICLE; HUMAN; METABOLISM; OSTEOCLAST; OSTEOLYSIS; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BONE RESORPTION; HUMANS; OSTEOCLASTS; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; PROTEIN TYROSINE PHOSPHATASES; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TYROSINE;

EID: 70349326248     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-009-8811-5     Document Type: Review

References (147)

1. Wlodarski, K. H. (1990) Properties and origin of osteoblasts. Clin. Orthop. Relat. Res. 252, 276-93.
2. Polig, E., and Jee, W. S. (1990) A model of osteon closure in cortical bone. Calcif. Tissue Int. 47, 261-269.
3. Aarden, E. M., Burger, E. H., and Nijweide, P. J. (1994) Function of osteocytes in bone. J. Cell. Biochem. 55, 287-299.
4. Aubin, J. E., Liu, F., Malaval, L., and Gupta, A. K. (1995) Osteoblast and chondroblast differentiation. Bone 17, 77S-83S.
5. Dodds, R. A., Ali, N., Pead, M. J., and Lanyon, L. E. (1993) Early loading-related changes in the activity of glucose 6-phosphate dehydrogenase and alkaline phosphatase in osteocytes and periosteal osteoblasts in rat fibulae in vivo. J. Bone Miner. Res. 8, 261-267.
6. Cheng, B., Zhao, S., Luo, J., Sprague, E., Bonewald, L. F., and Jiang, J. X. (2001) Expression of functional gap junctions and regulation by fluid flow in osteocyte-like MLO-Y4 cells. J. Bone Miner. Res. 16, 249-259.
7. Lanyon, L. E. (1993) Osteocytes, strain detection, bone modeling and remodeling. Calcif. Tissue Int. 53, S102-S017.
8. Parfitt, A. M. (2002) Physiologic and pathogenetic significance of bone histomorphometric data. In:Disorders of Bone Mineral Metabolism, 2nd ed. pp. 469-485, Coe, F. L., and Favus, M. J. (ed.), Lippincott Williams and Wilkins, Baltimore, MD, USA.
9. Roodman, G. D. (1999) Cell biology of the osteoclast. Exp. Hematol. 27, 1229-1241.
10. Geiger, B., Bershadsky, A., Pankov, R., and Yamada, K. M. (2001) Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat. Rev. Mol. Cell Biol. 2, 793-805.
11. Reddy, S. V. (2004) Regulatory mechanisms operative in osteoclasts. Crit. Rev. Eukaryot. Gene Expr. 14, 255-270.
12. Baron, R., Vignery, A., and Tran Van, P. (1980) The significance of lacunar erosion without osteoclasts: studies on the reversal phase of the remodeling sequence. Metab. Bone Dis. Rel. Res. 2S, 35-40.
13. Aguila, H. L., and Rowe, D. W. (2005) Skeletal development, bone remodeling, and hematopoiesis. Immunol. Rev. 208, 7-18.
14. Nicolas, V., Prewett, A., Bettica, P., Mohan, S., Finkelman, R. D., Baylink, D. J., and Farley, J. R. (1994) Age-related decreases in insulin-like growth factor-I and transforming growth factor-b in femoral cortical bone from both men and women: implications for bone loss with aging. J. Clin. Endocrinol. Metab. 78, 1011-1016.
15. Ivey, J. L., and Baylink, D. J. (1981) Postmenopausal osteoporosis: proposed roles of defective coupling and estrogen deficiency. Metab. Bone Dis. Relat. Res. 3, 3-7.
16. Parisien, M., Silverberg, S. J., Shane, E., Dempster, D. W., and Bilezikian, J. P. (1990) Bone disease in primary hyperparathyroidism. Endocrinol. Metab. Clin. North Am. 19, 19-34.
17. Mosekilde, L., and Melsen, F. (1978) A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism. Acta Med. Scand. 204, 97-102.
18. Kraut, J. A. (1995) The role of metabolic acidosis in the pathogenesis of renal osteodystrophy. Adv. Ren. Replace. Ther. 2, 40-51.
19. Krane, S. M., and Simon, L. S. (1987) Metabolic consequences of bone turnover in Paget's disease of bone. Clin. Orthop. Relat. Res. 217, 26-36.
20. Levine, J. P. (2006) Pharmacologic and nonpharmacologic management of osteoporosis. Clin. Cornerstone 8, 40-53.
21. De Vernejoul, M. C., and Benichou, O. (2001) Human osteopetrosis and other sclerosis disorders: recent genetic developments. Calcif. Tissue Int. 69, 1-6.
22. Miyamoto, T., and Suda, T. (2003) Differentiation and function of osteoclasts. Keio J. Med. 52, 1-7.
23. James, I. E., Dodds, R. A., Lee-Rykaczewski, E., Eichman, C. F., Connor, J. R., Hart, T. K., Maleeff, B. E., Lackman, R. D., and Gowen, M. (1996) Purification and characterization of fully functional human osteoclast precursors. J. Bone Miner. Res. 11, 1608-1618.
24. Fallon, M. D., Teitelbaum, S. L., and Kahn, A. J. (1983) Multinucleation enhances macrophage-mediated bone resorption. Lab. Invest. 49, 159-164.
25. Geiger, B., Bershadsky, A., Pankov, R., and Yamada, K. M. (2001) Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat. Rev. Mol. Cell Biol. 2, 793-805.
26. Teti, A., Marchisio, P. C., and Zallone, A. Z. (1991) Clear zone in osteoclast function: role of podosomes in regulation of bone-resorbing activity. Am. J. Physiol. 261, C1-C7.
27. Luxenburg, C., Geblinger, D., Klein, E., Anderson, K., Hanein, D., Geiger, B., and Addadi, L. (2007) The architecture of the adhesive apparatus of cultured osteoclasts: from podosome formation to sealing zone assembly. PLoS ONE 2, e179.
28. Destaing, O., Saltel, F., Geminard, J. C., Jurdic, P., and Bard, F. (2003) Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. Mol. Biol. Cell 14, 407-416.
29. Stenbeck, G., and Horton, M. A. (2000) A new specialized cell-matrix interaction in actively resorbing osteoclasts. J. Cell Sci. 113, 1577-1587.
30. Teitelbaum, S. L., and Ross, F. P. (2003) Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638-649.
31. Delaisse, J. M., Andersen, T. L., Engsig, M. T., Henriksen, K., Troen, T., and Blavier, I. (2003) Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc. Res. Tech. 61, 504-513.
32. +-adenosine triphosphatase in a Japanese patient with infantile malignant osteopetrosis. Bone 30, 436-439.
33. Frattini, A., Pangrazio, A., Susani, L., Sobacchi, C., Mirolo, M., Abinun, M., Andolina, M., Flanagan, A., Horwitz, E. M., Mihci, E., Notarangelo, L. D., Ramenghi, U., Teti, A., Van Hove, J., Vujic, D., Young, T., Albertini, A., Orchard, P. J., Vezzoni, P., and Villa, A. (2003) Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J. Bone Miner. Res. 18, 1740-1747.
34. Motyckova, G., Weilbaecher, K. N., Horstmann, M., Rieman, D. J., Fisher, D. Z., and Fisher, D. E. (2001) Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc. Natl. Acad. Sci. USA 98, 5798-5803.
35. Tanaka, S., Nakamura, I., Inoue, J., Oda, H., and Nakamura, K. (2003) Signal transduction pathways regulating osteoclast differentiation and function. J. Bone Miner. Metab. 21, 123-133.
36. Lee, S. K., and Lorenzo, J. (2006) Cytokines regulating osteoclast formation and function. Curr. Opin. Rheumatol. 18, 411-418.
37. Pixley, F. J., and Stanley, E. R. (2004) CSF-1 regulation of the wandering macrophage: Complexity in action. Trends Cell Biol. 14, 628-638.
38. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., and Martin, T. J. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357.
39. Boyle, W. J., Simonet, W. S., and Lacey, D. L. (2003) Osteoclast differentiation and activation. Nature 423, 337-342.
40. Teitelbaum, S. L. (2000) Bone resorption by osteoclasts. 289, 1504-1508.
41. Blair, H. C., Robinson, L. J., and Zaidi, M. (2005) Osteoclast signaling pathways. Biochem. Biophys. Res. Commun. 328, 728-738.
42. Asagiri, M., and Takayanagi, H. (2007) The molecular understanding of osteoclast differentiation. Bone 40, 251-264.
43. Ross, F. P., and Teitelbaum, S. L. (2005) avb3 and macrophage colony-stimulating factor: partners in osteoclast biology. Immunol. Rev. 208, 88-105.
44. Teitelbaum, S. L. (2005) Osteoclasts and integrins. Ann. N. Y. Acad. Sci. 1068, 95-99.
45. Sheng, M. H.-C., Wergedal, J. E., Mohan, S., and Lau, K.-H. W. (2008) Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity. FEBS Lett. 582, 1451-1458.
46. 3 integrins in osteoclast function. J. Bone Miner. Metab. 25, 337-344.
47. Wada, T., Nakashima, T., Hiroshi, N., and Penninger, J. M. (2006) RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 12, 17-25.
48. Roth, P., and Stanley, E. R. (1992) The biology of CSF-1 and its receptor. Curr. Top. Microbiol. Immunol. 181, 141-167.
49. Soriano, P., Montgomery, C., Geske, R., and Bradley, A. (1991) Targeted disruption of the c-src proto-oncogene leads to osteoporosis in mice. Cell 64, 693-702.
50. c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90, 1622-1627.
51. -/- mice. J. Cell Biol. 178, 1053-1064.
52. 3 integrins are osteosclerotic because of dysfunctional osteoclasts. J. Clin. Invest. 105, 433-440.
53. src substrate. Mol. Cell. Biol. 11, 5113-5124.
54. c-src, preferentially on ruffled border membranes. FEBS Lett. 323, 85-89.
55. Ochoa, G. C., Slepnev, V. I., Neff, L., Ringstad, N., Takei, K., Daniell, L., Kim, W., Cao, H., McNiven, M., Baron, R., De Camilli, P. (2000) A functional link between dynamin and the actin cytoskeleton at podosomes. J. Cell Biol. 150, 377-389.
56. c-src expression during osteoclast formation in vitro. Mol. Endocrinol. 7, 1313-1318.
57. 3 integrin-mediated signaling, cell adhesion, and osteoclast motility. J. Cell Biol. 152, 181-195.
58. Miyazaki, T., Takayanagi, H., Isshiki, M., Takahashi, T., Okada, M., Fukui, Y., Oda, H., Nakamura, K., Hirai, H., Kurokawa, T., and Tanaka, S. (2000) In vitro and in vivo suppression of osteoclast function by adenovirus vector-induced csk gene. J. Bone Miner. Res. 15, 41-51.
59. Hall, T. J., Schaeublin, M., and Missbach, M. (1994) Evidence that c-src is involved in the process of osteoclastic bone resorption. Biochem. Biophys. Res. Commun. 199, 1237-1244.
60. c-src tyrosine kinase inhibitor, inhibits osteoclast bone resorption in vitro and hypercalcemia in vivo. J. Clin. Invest. 91, 2791-2795.
61. Blair, H. C., Jordan, S. E., Peterson, T. G., and Barnes, S. (1996) Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J. Cell. Biochem. 61, 629-637.
62. Missabach, M., Jeschke, M., Feyen, J., Muller, K., Glatt, M., Green, J., and Susa, M. (1999) A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo. Bone 24, 437-439.
63. Lau, K.-H. W., Wu, L.-W., Sheng, M. H.-C., Amoui, M., Suhr, S. M., and Baylink, D. J. (2006) A unique osteoclastic transmembrane protein-tyrosine phosphatase is a potential positive regulator of the c-src protein-tyrosine kinase activity, a mediator of osteoclast activity. J. Cell. Biochem. 97, 940-955.
64. c-src activating phosphatase. J. Cell. Biochem. 67, 432-438.
65. -/- mutant mice. Genes Dev. 11, 2835-2844.
66. Schwartzberg, P. (1998) The many faces of Src: multiple functions of a prototypical tyrosine kinase. Oncogene 17,1463-1468.
67. Violette, S. M., Guan, W., Bartlett, C., Smith, J. A., Bardelay, C., Antoine, E., Rickles, R. J., Mandine, E., van Schravendijk, M. R., Adams, S. E., Lynch, B. A., Shakespeare, W. C., Yang, M., Jacobsen, V. A., Takeuchi, C. S., Macek, K. J., Bohacek, R. S., Dalgarno, D. C., Weigele, M., Lesuisse, D., Sawyer, T. K., Baron, R. (2001) Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption. Bone 28, 54-64.
68. Miyazaki, T., Sanjay, A., Neff, L., Tanaka, S., Horne, W. C., and Baron, R. (2004) Src kinase activity is essential for osteoclast function. J. Biol. Chem. 279, 17660-17666.
69. Xing, L., Venegas, A. M., Chen, A., Garrett-Beal, L., Boyce, B. F., Varmus, H. E., and Schwartzberg, P. L. (2001) Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival. Genes Dev. 15, 241-253.
70. Boggon, T. J., and Eck, M. J. (2004) Structure and regulation of Src family kinases. Oncogene 23, 7918-7927.
71. Xu, W., Harrison, S. C., and Eck, M. J. (1997) Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602.
72. Moarefi, I., LaFevre-Bernt, M., Sicheri, F., Huse, M., Lee, C. H., Kuriyan, J., and Miller, W. T. (1997) Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385, 650-653.
73. Lau, K.-H. W., and Baylink, D. J. (1993) Phosphotyrosyl protein phosphatases: potential regulators of cell proliferation and differentiation. Crit. Rev. Oncogenesis 4, 451-471.
74. Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., and Mustelin, T. (2004). Protein tyrosine phosphatases in the human genome. Cell 117, 699-711.
75. c-src activating phosphatase. J. Cell. Biochem. 67, 432-438.
76. Barford, D., Das, A. K., and Egloff, M. P. (1998) The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu. Rev. Biophys. Biomol. Struct. 27, 133-164.
77. Zhang, Z. Y. (2002) Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development. Annu. Rev. Pharmacol. Toxicol. 42, 209-234.
78. Andersen, J. N., Mortensen, O. H., Peters, G. H., Drake, P. G., Iversen, L. F., Olsen, O. H., Jansen, P. G., Andersen, H. S., Tonks, N. K., and Møller, N. P. (2001) Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol. Cell. Biol. 21, 7117-7136.
79. Schmidt, A., Rutledge, S. J., Endo, N., Opas, E. E., Tanaka, H., Wesolowski, G., Leu, C. T., Huang, Z., Ramachandaran, C., Rodan, S. B., and Rodan, G. A. (1996) Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate. Proc. Natl. Acad. Sci. U.S.A. 93, 3068-3073.
80. Ducruet, A. P., Vogt, A., Wipf, P., and Lazo, J. S. (2005) Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease. Annu. Rev. Pharmacol. Toxicol. 45, 725-750.
81. Gu, H., and Neel, B. G. (2003) The 'Gab' in signal transduction. Trends Cell Biol. 13, 122-130.
82. Granot-Attas, S., Knobler, H., and Elson, A. (2007) Protein tyrosine phosphatases in osteoclasts. Crit. Rev. Eukaryot. Gene Expr. 17, 49-71.
83. Granot-Attas, S., and Elson, A. (2008) Protein tyrosine phosphatases in osteoclast differentiation, adhesion, and bone resorption. Eur. J. Cell Biol. 87, 479-490.
84. Frearson, J. A., and Alexander, D. R. (1997) The role of phosphotyrosine phosphatases in haematopoietic cell signal transduction. Bioassays 19, 417-427.
85. Poole, A. W., and Jones, M. L. (2005) A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Cell. Signal. 17, 1323-1332.
86. Neel, B. G., Gu, H., and Pao, L. (2003)The 'shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28, 284-293.
87. Umeda, S., Beamer, W. G., Takagi, K., Naito, M., Hayashi, S., Yonemitsu, H., Yi, T., and Shultz, L. D. (1999) Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density. Am. J. Pathol. 155, 223-233.
88. v mutant mice. Bone 25, 261-267.
89. Zhang, Z., Jimi, E., and Bothwell, A. L. (2003) Receptor activator of NF-κB ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis. J. Immunol. 171, 3620-3626.
90. Mary, F., Moon, C., Venaille, T., Thomas, M. L., Mary, D., and Bernard, A. (1999) Modulation of TCR signaling by β1 integrins: role of the tyrosine phosphatase SHP-1. Eur. J. Immunol. 29, 3887-3897.
91. Roach, T. I., Slater, S. E., White, L. S., Zhang, X., Majerus, P. W., Brown, E. J., and Thomas, M. L. (1998) The protein tyrosine phosphatase SHP-1 regulates integrin-mediated adhesion of macrophages. Curr. Biol. 8, 1035-1038.
92. Kruger, J., Butler, J. R., Cherapanov, V., Dong, Q., Ginzberg, H., Govindarajan, A., Grinstein, S., Siminovitch, K. A., and Downey, G. P. (2000) Deficiency of Src homology 2-containing phosphatase 1 results in abnormalities in murine neutrophil function: studies in motheaten mice. J. Immunol. 165, 5847-5859.
93. Tanuma, N., Nakamura, K., and Kikuchi, K. (1999) Distinct promoters control transmembrane and cytosolic protein tyrosine phosphatase epsilon expression during macrophage differentiation. Eur. J. Biochem. 259, 46-54.
94. Gil-Henn, H., Volohonsky, G., Toledano-Katchalski, H., Gandre, S., and Elson, A. (2000) Generation of novel cytoplasmic forms of protein tyrosine phosphatase epsilon by proteolytic processing and translational control. Oncogene 19, 4375-4384.
95. Chiusaroli, R., Knobler, H., Luxenburg, C., Sanjay, A., Granot-Attas, S., Tiran, Z., Miyazaki, T., Harmelin, A., Baron, R., and Elson, A. (2004) Tyrosine phosphatase epsilon is a positive regulatory of osteoclast function in vitro and in vivo. Mol. Biol. Cell 15, 234-244.
96. Kollet, O., Dar, A., Shivtiel, S., Kalinkovich, A., Lapid, K., Sztainberg, Y., Tesio, M., Samstein, R. M., Goichberg, P., Spiegel, A., Elson, A., and Lapidot, T. (2006) Osteoclasts degrade endosteal componets and promote mobilization of hematopoietic progenitor cells. Nat. Med. 12, 657-664.
97. Gil-Henn, H., and Elson, A. (2003) Tyrosine phosphatase-ε activates Src and supports the transformed phenotype of Neuinduced mammary tumor cells. J. Biol. Chem. 278, 15579-15586.
98. Yang, Q., Co, D., Sommercorn, J., and Tonks, N. K. (1993) Cloning and expression of PTP-PEST. A novel, human, nontransmembrane protein tyrosine phosphatase. J. Biol. Chem. 268, 6622-6628.
99. Gupta, A., Lee, B. S., Khadeer, M. A., Tang, Z., Chellaiah, M., Abu-Amer, Y., Goldknopf, J., and Hruska, K. A. (2003) Leupaxin is a critical adaptor protein in the adhesion zone of the osteoclast. J. Bone Miner. Res. 18, 669-685.
100. Shen, Y., Lyons, P., Cooley, M., Davidson, D., Veillette, A., Salgia, R., Griffin, J. D., and Schaller, M. D. (2000) The noncatalytic domain of protein-tyrosine phosphatase-PEST targets paxillin for dephosphorylation in vivo. J. Biol. Chem. 275, 1405-1413.
101. Chellaiah, M. A., Kuppuswamy, D., Lasky, L., and Linder, S. (2007) Phoshphorylation of a Wiscott-Aldrich syndrome protein-associated signal complex is critical in osteoclast bone resorption. J. Biol. Chem. 282, 10104-10116.
102. Sahu, S. N., Khadeer, M. A., Robertson, B. W., Núňez, S. M., Bai, G., and Gupta, A. (2007) Association of leupaxin with Src in osteoclasts. Am. J. Physiol. Cell Physiol. 292, C581-C590.
103. Côté, J. F., Chung, P. L., Theberge, J. F., Halle, M., Spencer, S., Lasky, L. A., and Tremblay, M. L. (2002) PSTPIP is a substrate of PTP-PEST and serves as a scaffold guiding PTP-PEST toward a specific dephosphorylation of WASP. J. Biol. Chem. 277, 2973-2986.
104. Dowbenko, D., Spencer, S., Quan, C., and Lasky, L. A. (1998) Identification of a novel polyproline recognition site in the cytoskeletal associated protein, prolin serine threonine phosphatase interacting protein. J. Biol. Chem. 273, 989-996.
105. Badour, K., Zhang, J., Shi, F., Leng, Y., Collins, M., and Siminovitch, K. A. (2004) Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation. J. Exp. Med. 199, 99-112.
106. Cory, G. O., Garg, R., Cramer, R., Ridley, A. J. (2002) Phosphorylation of tyrosine 291 enhances the ability of WASp to stimulate actin polymerization and filopodium formation. Wiskott-Aldrich Syndrome protein. J. Biol. Chem. 277, 45115-45121.
107. Ma, T., Samanna, V., and Chellaiah, M. A. (2008) Dramatic inhibition of osteoclast sealing ring formation and bone resorption in vitro by a WASP-peptide containing pTyr294 amino acid. J. Mol. Signal 3, 4.
108. Torres, E., and Rosen, M. K. (2006) Protein-tyrosine kinase and GTPase signals cooperate to phosphorylate and activate Wiskott-Aldrich syndrome protein (WASP)/neuronal WASP. J. Biol. Chem. 281, 3513-3520.
109. Miki, H., and Takenawa, T. (2003) Regulation of actin dynamics by WASP family proteins. J. Biochem. 134, 309-313.
110. Larsen, M., Tremblay, M. L., and Yamada, K. M. (2003) Phosphatases in cell-matrix adhesion and migration. Nat. Rev. Mol. Cell Biol. 4, 700-711.
111. Jamieson, J. S., Tumbarello, D. A., Halle, M., Brown, M. C., Tremblay, M. L., and Turner, C. E. (2005) Paxillin is essential for PTP-PEST-dependent regulation of cell spreading and motility: a role for paxillin kinase linker. J. Cell Sci. 118, 5835-5847.
112. Angers-Loustau, A. Côté, J. F., Charest, A., Dowbenko, D., Spencer, S., Lasky, L. A., and Tremblay, M. L. (1999) Protein tyrosine phosphatase-PEST regulates focal adhesion disassembly, migration, and cytokinesis in fibroblasts. J. Cell Biol. 144, 1019-1031.
113. Lyons, P. D., Dunty, J. M., Schaefer, E. M., and Schaller, M. D. (2001) Inhibition of the catalytic activity of cell adhesion kinase β by protein-tyrosine phosphatase-PEST-mediated dephosphorylation. J. Biol. Chem. 276, 24422-24431.
114. Chellaiah, M. A., Biswas, R. S., Yuen, D., Alvarez, U. M., and Hruska, K. A. (2001) Phosphatidylinositol 3,4,5-triphosphate directs association of Src homology 2-containing signaling proteins with gelsolin. J. Biol. Chem. 276, 47434-47444.
115. Mathew, S., George, S. P., Wang, Y., Siddiqui, M. R., Srinivasan, K., Tan, L., and Khurana, S. (2008) Potential molecular mechanism for c-Src kinase-mediated regulation of intestinal cell migration. J. Biol. Chem. 283, 22709-22722.
116. Wu, L.-W., Baylink, D. J., and Lau, K.-H. W. (1996) Molecular cloning and expression of a unique rabbit osteoclastic phosphotyrosyl phosphatase. Biochem. J. 316, 515-523.
117. Aguiar, R. C. T., Yakushijin, Y., Kharbanda, S., Tiwari, S., Freeman, G. J., and Shipp, M. A. (1999) PTPROt: an alternatively spliced and developmentally regulated B-lymphoid phosphatase that promotes G0/G1 arrest. Blood 94, 2403-2413.
118. Thomas, P. E., Wharram, B. L., Goyal, M., Wiggins, J. E., Holzman, L. B., and Wiggins, R. C. (1994) GLEPP1, a renal glomerular epithelial cell (podocyte) membrane protein-tyrosine phosphatase. Identification, molecular cloning, and characterization in rabbit. J. Biol. Chem. 269, 19953-19962.
119. Semiya, H., Sawabe, T., Inazawa, J., and Tsuruo, T. (1995) Cloning, expression and chromosomal localization of a novel gene for protein tyrosine phosphatase (PTP-U2) induced by various differentiation-inducing agents. Oncogene 10, 1731-1738.
120. Bodden, K., and Bixby, J. L. (1996). CRYP-2: a receptor-type tyrosine phosphatase selectively expressed by developing vertebrate neurons. J. Neurobiol. 31, 309-324.
121. Tagawa, M., Shirasawa, T., Yahagi, Y., Tomoda, T., Kuroyanagi, H., Fujimura, S., Sakiyama, S., and Maruyama, N. (1997) Identification of a receptor-type protein tyrosine phosphatase expressed in postmitotic maturing neurons: its structure and expression in the central nervous system. Biochem. J. 321, 865-871.
122. Motiwala, T., Ghoshal, K., Das, A., Majumder, S., Weichenhan, D., Wu, Y. Z., Holman, K., James, S. J., Jacob, S. T., and Plass, C. (2003) Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas. Oncogene 22, 6319-6331.
123. Andersen, J. N., Jansen, P. G., Echwald, S. M., Mortensen, P. H., Fukada, T., Del Vecchio, R., Tonks, N. K., Møller, N. P. (2004) A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage. FASEB J. 18, 8-30.
124. Wiggins, R. C., Wiggins, J. E., Goyal, M., Wharram, B. L., and Thomas, P. E. (1995) Molecular cloning of cDNAs encoding human GLEPP1, a membrane protein tyrosine phosphatase: characterization of the GLEPP1 protein distribution in human kidney and assignment of the GLEPP1 gene to human chromosome 12p12-p13. Genomics 27, 174-181.
125. Bischof, J. M., and Wevrick, R. (2005) Genome-wide analysis of gene transcription in the hypothalamus. Physiol. Genomics 22, 191-196.
126. Amoui, M., Baylink, D. J., Tillman, J. B., and Lau, K.-H. W. (2003) Expression of a structurally unique osteoclastic protein-tyrosine phosphatase is driven by an alternative intronic, cell-type-specific promoter. J. Biol. Chem. 278, 44273-44280.
127. Yang, J. H., Amoui, M., Strong, D. D., and Lau, K.-H. W. (2007) Characterization and comparison of the intronic promoter of murine osteoclastic protein-tyrosine phosphatase, PTP-oc, with the human PTP-oc promoter. Arch. Biochem. Biophys. 465, 72-81.
128. Wang, Z., Bhattacharya, N., Meyer, M. K., Seimiya, H., Tsuruo, T., Tonani, J. A., and Magnuson, N. S. (2001) Pim-1 negatively regulates the activity of PTP-U2S phosphatase and influences terminal differentiation and apoptosis of monoblastoid leukemia cells. Arch. Biochem. Biophys. 390, 9-18.
129. Jacob, S. T., and Motiwala, T. (2005) Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy. Cancer Gene Ther. 12, 665-672.
130. Suhr, S. M., Pamula, S., Baylink, D. J., and Lau, K.-H. W. (2001) Antisense oligodeoxynucleotide evidence that a unique osteoclastic protein-tyrosine phosphatase is essential for osteoclastic resorption. J. Bone Miner, Res. 16, 1795-1803.
131. Amoui, M., Suhr, S. M., Baylink, D. J., and Lau, K.-H. W. (2004)Anosteoclastic protein-tyrosine phosphatasemay play a role in the differentiation and activity of human monocytic U-937 cell-derived, osteoclast-like cells. Am. J. Physiol. Cell Physiol. 287, C874-C884.
132. Amoui, M., Sheng, M. H.-C., Chen, S.-T., Baylink, D. J., and Lau, K.-H. W. (2007) A transmembrane osteoclastic protein-tyrosine phosphatase regulates osteoclast activity in part by promoting osteoclast survival through c-Src-dependent activation of NFkB and JNK2. Arch. Biochem. Biophys. 463, 47-59.
133. Lau, K.-H. W., Wu, L.-W., Sheng, M. H.-C., Amoui, M., Suhr, S. M., and Baylink, D. J. (2006) A unique osteoclastic transmembrane protein-tyrosine phosphatase is a potential positive regulator of the c-src protein-tyrosine kinase activity, a mediator of osteoclast activity. J. Cell. Biochem. 97, 940-955.
134. Walsh, N. C., Cahill, M., Carninci, P., Kawai, J., Okazaki, Y., Hayashizaki, Y., Hume, D. A., and Cassady, A. I. (2003) Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene. Gene 307, 111-123.
135. Sheng, M. H.-C., Amoui, M., Srivastava, A. K., Wergedal, J. E., and Lau, K.-H. W. (2007) Transgenic overexpression of osteoclastic protein-tyrosine phosphatase, PTP-oc, in cells of osteoclastic lineage led to increased bone resorption and marked reduction in trabecular bone mass and density in adult mice. J. Bone Miner. Res. 22 (Suppl. 1), S84, abstract # O112.
136. Wharram, B. L., Goyal, M., Gillespie, P. J., Wiggins, J. E., Kershaw, D. B., Holzman, L. B., Dysko, R. C., Saunders, T. L., Samuelson, L. C., and Wiggins, R. C. (2000) Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate. J. Clin. Invest. 106, 1281-1290.
137. Miyazaki, T., Neff, L., Tanaka, S., Horne, W. C., and Baron, R. (2003) Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J. Cell Biol. 160, 709-718.
138. Chen, B., and Bixby, J. L. (2005)Anovel substrate of receptor tyrosine phosphatase PTPRO is required for nerve growth factor-induced process outgrowth. J. Neurosci. 25, 880-888.
139. Chen, L., Juszczynski, P., Takeyama, K., Aguiar, R. C., and Shipp, M. A. (2006) Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation. Blood 108, 3428-3433.
140. Shintani, T., Ihara, M., Sakuta, H., Takahashi, H., Watakabe, I., and Noda, M. (2006) Eph receptors are negatively controlled by protein tyrosine phosphatase receptor type O. Nature Neurosci. 9, 761-769.
141. Zou, W., Kitaura, H., Reeve, J., Long, F., Tybulewicz, V. L., Shattil, S. J., Ginsberg, M. H., Ross, F. P., and Teitelbaum, S. L. (2007) Syk, c-Src, the αvβ3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J. Cell Biol. 176, 877-888.
142. Mundy, G. R., and Elefteriou, F. (2006) Boning up on ephrin signaling. Cell 126, 441-443.
143. Yang, J. H., Amoui, M., and Lau, K.-H. W. (2007) Targeted deletion of the osteoclast protein-tyrosine phosphatase (PTP-oc) promoter prevents RANKL-mediated osteoclastic differentiation of RAW264.7 cells. FEBS Lett. 581, 2503-2508.
144. Fang, K. S., Sabe, H., Saito, H., and Hanafusa, H. (1994) Comparative study of three protein-tyrosine phosphatases. Chicken protein-tyrosine phosphatase l dephosphorylates c-Src tyrosine 527. J. Biol. Chem. 269, 20194-20200.
145. Arias-Salgado, E. G., Haj, F., Dubois, C., Moran, B., Kasirer-Friede, A., Furie, B. S., Furie, B., Neel, B. G., Shattil, S. J. (2005) PTP-1B is an essential positive regulator of platelet integrin signaling. J. Cell Biol. 170, 837-845.
146. Shiota, M., Tanihiro, T., Nakagawa, Y., Aoki, N., Ishida, N., Miyazaki, K., Ullrich, A., Miyazaki, H. (2003) Protein tyrosine phosphatase PTP20 induces actin cytoskeleton reorganization by dephosphorylation p190 RhoGAP in rat ovarian granulose cells stimulated with follicle-stimulating hormone. Mol. Endocrinol. 17, 534-549.
147. Chiarugi, P., Cirri, P., Taddei, L., Giannoni, E., Camici, G., Manao, G., Raugei, G., and Rampoin, G. (2000) The low Mr protein-tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation. J. Biol. Chem. 275, 4640-4646.